Lv1
20 积分 2023-10-11 加入
Resolving Loss of Response to Ustekinumab in Crohn's Disease: POWER Through or Switch Treatment?
8个月前
已完结
Interleukin-22: the hub bridging gut homeostasis and metabolism
8个月前
已完结
Mechanistic insights into taxane-induced psychiatric adverse events: a global pharmacovigilance and experimental investigation
9个月前
已完结
Ulcerative colitis
9个月前
已完结
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection
9个月前
已完结
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
9个月前
已完结
Biologic Switch Timing and Risk of Infection in Patients With Ulcerative Colitis/Crohn’s Disease: A Retrospective Study
9个月前
已完结
Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor–Inhibitor Treatment for Autoimmune Diseases
9个月前
已完结
Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation
9个月前
已完结
Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites
9个月前
已完结
皖公网安备34019202002308
